Calithera Biosciences Ownership | Who Owns Calithera Biosciences?


OverviewForecastChart

Calithera Biosciences Ownership Summary


100.00% retail investors. Vanguard US Opportunities Ins USD Acc is the top mutual fund, with 0.32% of its assets in Calithera Biosciences shares.

CALA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCalithera Biosciences--100.00%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20221-2---1---
Jun 30, 20221-98.18%500-100.00%-0.00%1-96.00%--100.00%
Mar 31, 202255-5.17%42,446,3484.41%541.79%25-10.71%13-27.78%
Dec 31, 202158-17.14%40,652,493-11.47%551.43%28-9.68%18-18.18%
Sep 30, 202170-13.58%45,921,007-3.04%611.51%31-16.22%22-26.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Opportunities Ins USD Acc15.70K0.32%-24.57K
JHVIT Total Stock Market Index I171.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 27, 2023PAKIANATHAN DEEPIKA-Sell$452.16
Nov 11, 2021Orford Keith DirectorSell$42.41K
Nov 10, 2021Orford Keith DirectorSell$25.70K
Nov 10, 2021Molineaux Susan PRESIDENT & CEOBuy$84.67K
Nov 10, 2021DRACHMAN JONATHAN G-Buy$171.90K

Insider Transactions Trends


DateBuySell
2023 Q1-1
2022 Q3--
2022 Q2--
2022 Q1--
2021 Q433

CALA Ownership FAQ


Who Owns Calithera Biosciences?

Calithera Biosciences shareholders are primarily institutional investors at 0%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Calithera Biosciences's industry, Biotech Stocks , is 44.70%, which Calithera Biosciences falls below.

Does Blackrock own Calithera Biosciences?

BlackRock is not among the top 10 institutional shareholders of Calithera Biosciences.

Who is the top mutual fund holder of Calithera Biosciences shares?

Vanguard US Opportunities Ins USD Acc is the top mutual fund holder of Calithera Biosciences shares, with 0.32% of its total shares outstanding invested in 15.7K Calithera Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools